瘦型与非瘦型非酒精性脂肪性肝病代谢功能障碍负担比较的系统综述与Meta分析
该系统综述与Meta分析检索Medline和Embase至2022年3月3日,纳入85篇文章,比较瘦型非酒精性脂肪性肝病(NAFLD)与非瘦型NAFLD及非NAFLD人群的代谢功能障碍程度。瘦型NAFLD占全球人群13.11%(95%CI 10.26%-16.62%),亚洲14.55%(95%CI 11.32%-18.51%)。代谢功能障碍程度呈体重依赖性,瘦型NAFLD患者代谢功能障碍显著轻于超重和肥胖NAFLD患者。
要点
- 瘦型NAFLD占全球人群13.11%,亚洲14.55%。
- 瘦型NAFLD中糖尿病患病率19.56%,肥胖NAFLD为45.70%(P < .01)。
- 瘦型NAFLD的空腹血糖和收缩压、舒张压显著低于超重和肥胖NAFLD。
核心结论
- NAFLD中的代谢功能障碍呈体重依赖性,瘦型NAFLD患者的代谢健康状况显著优于超重和肥胖NAFLD患者。
- 过度依赖代谢功能障碍来定义脂肪肝可能是一个缺陷,会潜在排除先前已表征的NAFLD。
研究设计与样本
- 系统综述与Meta分析,检索Medline和Embase数据库从建库至2022年3月3日。
- 纳入标准为报告瘦型NAFLD患者基线代谢参数的文章,共纳入85篇文章,采用亚组分析进行比较。
主要发现
- 瘦型NAFLD占全球人群13.11%(95%CI 10.26%-16.62%),亚洲为14.55%(95%CI 11.32%-18.51%)。
- 瘦型NAFLD中糖尿病患病率为19.56%(95%CI 15.28%-24.69%),肥胖NAFLD中为45.70%(95%CI 35.01%-56.80%)(P < .01)。
- 瘦型NAFLD患者的空腹血糖、收缩压和舒张压值显著低于超重和肥胖NAFLD患者。
- 代谢功能障碍程度呈体重依赖性,瘦型NAFLD的代谢功能障碍显著少于超重NAFLD。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Nonalcoholic fatty liver disease (NAFLD) is traditionally associated with obesity. However, there is a subtype of NAFLD, namely NAFLD in lean, that occurs without obesity. However, a recent call to redefine NAFLD to metabolic-associated fatty liver disease focuses on obesity and metabolic dysfunction. Criticism has arisen from the perceived over emphasis on systemic comorbidities, which may disadvantage the lean. The current analysis seeks to quantify the degree of metabolic dysfunction in NAFLD in lean and compare with NAFLD in overweight and obese and non-NAFLD. METHODS: Medline and Embase databases were searched from inception to March 3, 2022. The inclusion criteria were articles with NAFLD in lean patients presenting with baseline metabolic parameters. Comparisons were conducted with subgroup analysis. RESULTS: Eighty-five articles were included in the meta-analysis. NAFLD in lean accounted for 13.11% (95% confidence interval [CI], 10.26%-16.62%) of the global population and 14.55% (95% CI, 11.32%-18.51%) in Asia. The degree of metabolic dysfunction was weight dependent with significantly less metabolic dysfunction in NAFLD in lean subjects as compared with NAFLD in overweight counterparts. For NAFLD in lean, only 19.56% (95% CI, 15.28%-24.69%) of the subjects were diabetic, whereas 45.70% (95% CI, 35.01%-56.80%) of obese subjects with NAFLD had diabetes (P < .01). Fasting blood glucose and systolic and diastolic blood pressure values were significantly lower in subjects with NAFLD in lean than in overweight and obese. CONCLUSION: The current analysis highlights the weight-dependent nature of metabolic dysfunction in NAFLD. Lean subjects with NAFLD were significantly less metabolically unhealthy than were obese and overweight persons with NAFLD. An overreliance on metabolic dysfunction in defining fatty liver will be a flaw in potentially excluding previously characterized NAFLD.
引用
- Tang A, Ng CH, Phang PH, et al. Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs Non-lean NAFLD - A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2022. PMID: 35863685. doi:10.1016/j.cgh.2022.06.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。